Anxibloc

Anxibloc may be available in the countries listed below.

Ingredient matches for Anxibloc

Clobazam

Clobazam is reported as an ingredient of Anxibloc in the following countries:

• Indonesia

International Drug Name Search

AT III

AT III may be available in the countries listed below.

Ingredient matches for AT III

Antithrombin Iii

Antithrombin III is reported as an ingredient of AT III in the following countries:

• Brazil


• Germany


• Italy

International Drug Name Search

Atenolol Solka

Atenolol Solka may be available in the countries listed below.

Ingredient matches for Atenolol Solka

Atenolol

Atenolol is reported as an ingredient of Atenolol Solka in the following countries:

• Costa Rica


• Dominican Republic


• El Salvador


• Honduras


• Nicaragua

International Drug Name Search

Atrovent HFA

Atrovent HFA is a brand name of ipratropium, approved by the FDA in the following formulation(s):

ATROVENT HFA (ipratropium bromide - aerosol, metered; inhalation)

• 
  Manufacturer: BOEHRINGER INGELHEIM
  
  Approval date: November 27, 2004
  
  Strength(s): 0.021MG/INH ^[RLD]

Has a generic version of Atrovent HFA been approved?

No. There is currently no therapeutically equivalent version of Atrovent HFA available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Atrovent HFA. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Stabilized medicinal aerosol solution formulations
  Patent 5,676,930
  Issued: October 14, 1997
  Inventor(s): Jager; Paul Donald & Kontny; Mark James & Nagel; Jurgen Hubert
  Assignee(s): Boehringer Ingelheim Pharmaceuticals, Inc.
  Stabilized medicinal aerosol solution formulations comprising medicaments that degrade or decompose by interaction with solvents or water, an HFC propellant, a cosolvent and an acid are described. Further, specific medicinal aerosol solution formulations comprising ipratropium bromide or fenoterol, ethyl alcohol, 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoropropane, and either an inorganic acid or an organic acid are described. The acids are present in amounts sufficient to reduce the degradation of the medicaments to acceptable levels.
  
  Patent expiration dates:
  
  
  • October 14, 2014
    
    ✓ 
    Drug product
  
  



• 
  Medicinal aerosol formulations
  Patent 5,683,677
  Issued: November 4, 1997
  Inventor(s): Purewal; Tarlochan S. & Greenleaf; David J.
  Assignee(s): Riker Laboratories, Inc.
  A self-propelling aerosol formulation which may be free from CFC's which comprises a medicament, 1,1,1,2-tetrafluoroethane, a surface active agent and at least one compound having a higher polarity than 1,1,1,2-tetrafluoroethane.
  
  Patent expiration dates:
  
  
  • November 4, 2014
    
    ✓ 
    Drug product
  
  



• 
  Stainless steel canister for propellant-driven metering aerosols
  Patent 6,739,333
  Issued: May 25, 2004
  Inventor(s): Hubert; Hoelz & Richard Thomas; Lostritto & Juergen; Nagel & Julio César; Vega
  Assignee(s): Boehringer Ingelheim Pharma KG
  The present invention relates to corrosion resistant stainless steel canisters for propellant-containing aerosol forumlations for use in propellant gas-operated inhalers.
  
  Patent expiration dates:
  
  
  • May 26, 2020
    
    ✓ 
    Drug product
  
  



• 
  Stainless steel canister for propellant-driven metering aerosols
  Patent 6,983,743
  Issued: January 10, 2006
  Inventor(s): Hoelz; Hubert & Lostritto; Richard Thomas & Nagel; Juergen & Vega; Julio César
  Assignee(s): Boehringer Ingelheim Pharma KG
  The present invention relates to corrosion resistant stainless steel canisters for propellant-containing aerosol formulations for use in propellant gas-operated inhalers.
  
  Patent expiration dates:
  
  
  • May 26, 2020
    
    ✓ 
    Drug product
  
  

See also...

• Atrovent HFA Aerosol Suspension Consumer Information (Wolters Kluwer)
• Atrovent HFA Consumer Information (Cerner Multum)
• Ipratropium Aerosol Suspension Consumer Information (Wolters Kluwer)
• Ipratropium Solution Consumer Information (Wolters Kluwer)
• Ipratropium inhalation Consumer Information (Cerner Multum)
• Alti-Ipratropium Advanced Consumer Information (Micromedex)
• Alti-Ipratropium With Preservative Advanced Consumer Information (Micromedex)
• Apo-Ipravent Advanced Consumer Information (Micromedex)
• Ipratropium Bromide Nebuamp Advanced Consumer Information (Micromedex)
• Ipratrovent Sterules Advanced Consumer Information (Micromedex)
• Ratio-Ipratropium Advanced Consumer Information (Micromedex)
• Ratio-Ipratropium Udv Advanced Consumer Information (Micromedex)
• Ipratropium Inhalation, oral/nebulization Advanced Consumer Information (Micromedex)
• Ipratropium Bromide AHFS DI Monographs (ASHP)

Mircette

In the US, Mircette (desogestrel/ethinyl estradiol systemic) is a member of the drug class contraceptives and is used to treat Abnormal Uterine Bleeding, Birth Control, Endometriosis, Gonadotropin Inhibition and Polycystic Ovary Syndrome.

US matches:

• Mircette

Ingredient matches for Mircette

Desogestrel

Desogestrel is reported as an ingredient of Mircette in the following countries:

• United States

Ethinylestradiol

Ethinylestradiol is reported as an ingredient of Mircette in the following countries:

• United States

International Drug Name Search

Mannitolo Fresenius Kabi

Mannitolo Fresenius Kabi may be available in the countries listed below.

Ingredient matches for Mannitolo Fresenius Kabi

Mannitol

Mannitol is reported as an ingredient of Mannitolo Fresenius Kabi in the following countries:

• Italy

International Drug Name Search

Buflo

Buflo may be available in the countries listed below.

Ingredient matches for Buflo

Buflomedil

Buflomedil hydrochloride (a derivative of Buflomedil) is reported as an ingredient of Buflo in the following countries:

• Taiwan

International Drug Name Search

Cefazolin Vatchem

Cefazolin Vatchem may be available in the countries listed below.

Ingredient matches for Cefazolin Vatchem

Cefazolin

Cefazolin is reported as an ingredient of Cefazolin Vatchem in the following countries:

• Georgia

International Drug Name Search

Zitep

Zitep may be available in the countries listed below.

Ingredient matches for Zitep

Sulfadiazine

Sulfadiazine is reported as an ingredient of Zitep in the following countries:

• Mexico

International Drug Name Search

Lecetrin

Lecetrin may be available in the countries listed below.

Ingredient matches for Lecetrin

Levocetirizine

Levocetirizine dihydrochloride (a derivative of Levocetirizine) is reported as an ingredient of Lecetrin in the following countries:

• Bangladesh

International Drug Name Search

Cefixim HG.Pharm

Cefixim HG.Pharm may be available in the countries listed below.

Ingredient matches for Cefixim HG.Pharm

Cefixime

Cefixime is reported as an ingredient of Cefixim HG.Pharm in the following countries:

• Vietnam

International Drug Name Search

Cloxine

Cloxine may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Cloxine

Cloxacillin

Cloxacillin benzathine (a derivative of Cloxacillin) is reported as an ingredient of Cloxine in the following countries:

• France

International Drug Name Search

Spashi

Spashi may be available in the countries listed below.

Ingredient matches for Spashi

Scopolamine

Scopolamine butylbromide (a derivative of Scopolamine) is reported as an ingredient of Spashi in the following countries:

• Indonesia

International Drug Name Search

Levinox

Levinox may be available in the countries listed below.

Ingredient matches for Levinox

Letrozole

Letrozole is reported as an ingredient of Levinox in the following countries:

• Greece

International Drug Name Search